AAOI
Applied Optoelectronics, Inc.
AAOI has the edge over TRT overall, supported by stronger valuation and stronger modeled upside.
TRT
Trio-Tech International
TRT has lower modeled downside risk, despite its lower overall score.
AAOI Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
AAOI's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
TRT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Under pressure | |
| Strong |
TRT's revenue, profitability and balance sheet are currently healthy, but its cash flow is under pressure.
AAOI PE Valuation
AAOI has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 18x next year's earnings.
TRT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $0.56 | -90% |
| Fair | 24x | $1.46 | -74% |
| Expensive | 47x | $2.81 | -50% |
| Current | 93x | $5.60 | — |
Historical ranges are pointers, not guarantees.
TRT's PE is in its expensive range at 93x.
AAOI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect AAOI to return to profit, with revenue growing. However, they disagree widely on these estimates.
TRT Forward outlook
There aren't enough analyst estimates for TRT to show an outlook.
AAOI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.98 | — |
| Q3 2026 | -$0.42 | +$3.02 |
| Q2 2026 | -$0.77 | +$2.81 |
| Q1 2026 | -$0.65 | +$3.43 |
| Q4 2025 | -$0.64 | +$3.86 |
| Q3 2025 | -$3.44 | -$1.41 |
| Q2 2025 | -$3.58 | -$1.70 |
| Q1 2025 | -$4.08 | -$2.29 |
| Q4 2024 | -$4.50 | -$2.75 |
AAOI is still losing money, but far less than before: $0.42 per share over the past year, against $4.50 at its worst in late 2024.
TRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.06 | +100% |
| Q2 2026 | $0.00 | +$0.01 |
| Q1 2026 | $0.04 | +$0.05 |
| Q4 2025 | -$0.01 | -117% |
| Q3 2025 | $0.03 | -50% |
| Q2 2025 | -$0.01 | -108% |
| Q1 2025 | -$0.01 | -108% |
| Q4 2024 | $0.06 | -45% |
TRT has the edge over AAOI on earnings quality, reporting a profit while its opponent remains loss making.
AAOI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $269.9M | +127% |
| Q2 2026 | $191.9M | +86% |
| Q1 2026 | $151.1M | +51% |
| Q4 2025 | $134.3M | +34% |
| Q3 2025 | $118.6M | +82% |
| Q2 2025 | $103M | +138% |
| Q1 2025 | $99.9M | +146% |
| Q4 2024 | $100.3M | +66% |
AAOI has the edge over TRT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.5% | +15 points |
| Q2 2026 | -13% | +2.6 points |
| Q1 2026 | -8.6% | +0.3 points |
| Q4 2025 | -8.6% | -2.1 points |
| Q3 2025 | -15% | +10 points |
| Q2 2025 | -16% | +45 points |
| Q1 2025 | -8.9% | +44 points |
| Q4 2024 | -6.5% | +1 points |
AAOI's operating margin was −0.5% last quarter, up 15 points from the same quarter a year ago, near the top of its range since 2019.
TRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $19.9M | +29% |
| Q2 2026 | $14.9M | +40% |
| Q1 2026 | $16.5M | +124% |
| Q4 2025 | $15.6M | +82% |
| Q3 2025 | $15.5M | +58% |
| Q2 2025 | $10.7M | +9.5% |
| Q1 2025 | $7.4M | -29% |
| Q4 2024 | $8.6M | -29% |
TRT's revenue has grown year over year for six quarters in a row: $20M last quarter, up 29% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.3% | +6 points |
| Q2 2026 | -1.8% | -6.2 points |
| Q1 2026 | -0.5% | +4.2 points |
| Q4 2025 | 0.6% | +0.7 points |
| Q3 2025 | 0.3% | -1.1 points |
| Q2 2025 | 4.4% | +0.7 points |
| Q1 2025 | -4.7% | -5.2 points |
| Q4 2024 | 0% | -5.6 points |
TRT has the edge over AAOI on profitability, with a higher operating margin.
AAOI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$369.9M | -$291.2M |
| Q2 2026 | -$265.3M | -$174.4M |
| Q1 2026 | -$143.6M | -$64.3M |
| Q4 2025 | -$104.6M | -$51.6M |
| Q3 2025 | -$78.7M | -$58M |
| Q2 2025 | -$91M | -$86M |
| Q1 2025 | -$79.3M | -$45.1M |
| Q4 2024 | -$53M | -$48.4M |
AAOI has burned cash in almost every quarter: −$883M over the past year, against −$302M the year before.
TRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$4.1M | -567% |
| Q2 2026 | $244K | +$1.5M |
| Q1 2026 | $707K | +13% |
| Q4 2025 | -$152K | -108% |
| Q3 2025 | $887K | +$2.8M |
| Q2 2025 | -$1.2M | -$932K |
| Q1 2025 | $623K | -48% |
| Q2 2024 | -$289K | -123% |
TRT has the edge over AAOI on cash flow, with more consistent year-over-year improvement.
AAOI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +7.7% | +6.3M shares |
| 1 year | +39% | +24.5M shares |
| 3 years | +168% | +55.1M shares |
| 5 years | +224% | +60.7M shares |
| Available history | +340% | +67.9M shares |
AAOI has 88M diluted shares, up 39% from a year ago.
TRT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +27% | +2.4M shares |
| 1 year | +31% | +2.7M shares |
| 3 years | +33% | +2.8M shares |
| 5 years | +42% | +3.4M shares |
TRT has the edge over AAOI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $63,000 |
| Q2 2026 | — |
AAOI Net Leverage
AAOI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
TRT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.9x | Net Cash |
| Q2 2026 | -10.1x | Net Cash |
| Q1 2026 | -4.5x | Net Cash |
| Q4 2025 | -4.6x | Net Cash |
| Q3 2025 | -4.3x | Net Cash |
| Q2 2025 | -3.4x | Net Cash |
| Q1 2025 | -3.5x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
TRT has more cash than debt.
AAOI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.1 | Neutral |
| Stochastic | 4.8 | Oversold |
AAOI's weekly RSI is 35 (neutral) and its Stochastic is 5 (oversold).
TRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.4 | Neutral |
| Stochastic | 7.5 | Oversold |
TRT's weekly RSI is 41 (neutral) and its Stochastic is 8 (oversold).
AAOI PE vs Technology Sector
AAOI has no meaningful PE right now: it lost money over the past year.
TRT PE vs Technology Sector
| Metric | TRT | Sector median | Relative |
|---|---|---|---|
| PE | 93x | 28x | 235% above |
| PE % | 88 | 35 | 53 pts above |
TRT is trading at 93x earnings, a 235% premium to the Technology sector's median of 28x.
AAOI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $80.2 | 34% below |
| 20 week MA | $100.6 | 47% below |
| 50 week MA | $100.3 | 47% below |
| 100 week MA | $62.3 | 15% below |
| 200 week MA | $36.9 | 43% above |
AAOI has fallen below most of its moving averages, though it's still 43% above its 200-week average.
TRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.40 | 3.7% above |
| 20 week MA | $8.43 | 34% below |
| 50 week MA | $8.47 | 34% below |
| 100 week MA | $5.72 | 2.1% below |
| 200 week MA | $4.29 | 31% above |
TRT has the edge over AAOI on trend strength, trading above more of its moving averages.
AAOI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $11.5 | $8.77 | -24% |
| 2021 | $8.77 | $5.64 | -36% |
| 2022 | $5.64 | $1.95 | -65% |
| 2023 | $1.95 | $19.3 | +891% |
| 2024 | $19.3 | $37.7 | +95% |
| 2025 | $37.7 | $37.2 | -1.5% |
| 2026 YTD | $37.2 | $52.9 | +42% |
AAOI has the edge over TRT on returns for 2026, with the stronger performance.
TRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.11 | $1.96 | -7.1% |
| 2021 | $1.96 | $6.27 | +220% |
| 2022 | $6.27 | $2.29 | -63% |
| 2023 | $2.29 | $2.54 | +11% |
| 2024 | $2.54 | $2.96 | +17% |
| 2025 | $2.96 | $7.00 | +136% |
| 2026 YTD | $7.00 | $5.60 | -20% |
TRT's yearly returns have swung widely, from +220% in 2021 to −63% in 2022. It's down 20% so far in 2026.